You are here:

Home
NICE Guidance
Conditions and diseases
Cancer
Brain cancers

Brain cancers Products

A list of all our products on brain cancers

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting development

New and updated

New and updatedNew in the last 6 monthsUpdated in the last 6 months

Showing 1 product

Sort by: Date | Sort by Title

Status: In consultationRemove ‘Status: In consultation’ filter

Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and over [ID6407]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
9 April 2026
Expected publication date:
29 April 2026